Beresford Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Hyivy Health develops a holistic pelvic health device that treats, monitors, tracks, and helps prevent pelvic floor symptoms, along with connecting patients to clinicians and pelvic floor therapists.
Digital HealthFemTechHealthtechMedical Devices
Rachel Bartholomew(CEO & Founder)inKamyar Rounidej(Former Co-founder & first Chief Technical Officer)
Co-investorsAltitude AngelsBacchus Venture CapitalFACIT (Fight Against Cancer Innovation Trust)SOSVThe 51 VenturesWomen's Equity Lab+3 more
Mesentech develops prostaglandin prodrugs aimed at musculoskeletal regeneration.
BiotechHealthtechVancouver
David Hyman(Executive Officer)Robert Norman Young(Executive Officer, Director)Jay Mohr(Director)David Dvorak(Director)Jonathan Polak(Executive Officer, Director, Promoter)
BoardSamuel Wu(Director)in
Co-investors7G BioVenturesBoutique Venture PartnersWUTIF Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






